Novo Nordisk taps Anthropic's Claude to speed drug discovery

Integrating large language models like Claude into pharmaceutical R&D accelerates the identification of novel compounds by parsing vast datasets at unprecedented speeds. This partnership highlights a growing trend of biotech giants leveraging generative AI to reduce the time and cost associated with bringing life-saving treatments to market.